We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Catalent (CTLT) Shows Strength: Stock Adds 9.8% in Session
Catalent, Inc. (CTLT - Free Report) was a big mover last session, as the company saw its shares rise almost 10% on the day. The upside was driven by the company’s improved third-quarter fiscal 2017 results. Also, this led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 12% in the past one-month time frame.
The company has seen one positive estimate revisions in the past 30 days. Also, its Zacks Consensus Estimate moved higher over the same timeframe. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Catalent currently holds a Zacks Rank #2 (Buy).
Catalent, Inc. Price
Catalent, Inc. Price | Catalent, Inc. Quote
A top-ranked stock in the Medical – Drugs industry is Infinity Pharmaceuticals, Inc. sporting a Zacks Rank #1 (Strong Buy). You can the complete list of today’s Zacks #1 Rank stocks here.
Is CTLT going up? Or down? Predict to see what others think: Up or Down
The Best & Worst of Zacks
Today you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. From 1988 through 2015 this list has averaged a stellar gain of +25% per year. Plus, you may download 220 Zacks Rank #5 "Strong Sells." Even though this list holds many stocks that seem to be solid, it has historically performed 6X worse than the market. See these critical buys and sells free >>